Innate Pharma Provides Update on Lacutamab TELLOMAK Trial
Go back to Innate Pharma Provides Update on Lacutamab TELLOMAK Trial| Biophan Technologies, Inc. (AMEX: IPH) | Delayed: 0.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $0.04 | |||
| Open | $0.04 | 52 Week Low | $0.04 | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $0.00 | |||
| Volume | 71,303 | |||||
| (NASDAQ: IPHA) | Delayed: 1.58 -0.01 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.59 | 52 Week High | $ | |||
| Open | $1.56 | 52 Week Low | $ | |||
| Day High | $1.69 | P/E | N/A | |||
| Day Low | $1.53 | EPS | $ | |||
| Volume | 84,208 | |||||
